Apyx Medical (APYX) Net Income Growth (3y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -6.51% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 7.96% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -2.19% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 62.29% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 343.24% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 60.12% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 2.38% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Apyx Medical | 174.53 Mn | 143.65 Mn | 7.93 Mn | 15.34% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.34% |
| Dec 31, 2025 | 59.79% |
| Sep 30, 2025 | 30.39% |
| Jun 30, 2025 | 11.81% |
| Mar 31, 2025 | 11.25% |
| Dec 31, 2024 | 132.07% |
| Sep 30, 2024 | -3.72% |
| Jun 30, 2024 | -17.59% |
| Mar 31, 2024 | -15.66% |
| Dec 31, 2023 | -84.56% |
| Sep 30, 2023 | -7.78% |
| Jun 30, 2023 | 39.85% |
| Mar 31, 2023 | -21.88% |
| Dec 31, 2021 | -49.48% |
| Sep 30, 2021 | -114.29% |
| Jun 30, 2021 | -52.11% |
| Mar 31, 2021 | -66.82% |
| Dec 31, 2020 | 38.15% |
| Sep 30, 2020 | -61.31% |
| Jun 30, 2020 | -52.97% |
| Mar 31, 2020 | -5.01% |
| Dec 31, 2018 | 45.28% |
| Sep 30, 2018 | 32.77% |
| Jun 30, 2018 | 55.79% |
| Mar 31, 2018 | 60.30% |
| Dec 31, 2017 | -7.63% |
| Sep 30, 2017 | 37.88% |
| Jun 30, 2017 | -93.20% |
| Mar 31, 2017 | 44.02% |
| Dec 31, 2016 | -48.72% |
| Sep 30, 2016 | -41.45% |
| Jun 30, 2016 | -30.70% |
| Mar 31, 2016 | -68.13% |
| Dec 31, 2015 | -90.56% |
| Sep 30, 2015 | -509.76% |
| Jun 30, 2015 | -127.98% |
| Mar 31, 2015 | -88.37% |
| Dec 31, 2014 | -71.49% |
| Sep 30, 2014 | -256.73% |
| Jun 30, 2014 | -16.36% |
| Mar 31, 2014 | -178.18% |